达帕格利弗洛辛对心力衰竭与减少喷射率的影响:现实世界的研究
Francisca Augusto1, Patrícia Paiva1,2, Carolina Félix1,2
1Instituto de Farmacologia e Terapêutica Experimental da Faculdade de Medicina, Universidade de Coimbra, Coimbra, Portugal.
Journal of clinical pharmacology
|July 23, 2025
概括
在现实心力衰竭患者中,达帕格利弗洛辛改善了心脏功能并降低了体重. 虽然它通常是安全的,但它导致功能下降,特别是在老年人中.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 现实世界的证据.
背景情况:
- 临床试验表明,达帕格利弗洛辛对心力衰竭有减少喷射率 (HFrEF) 的益处.
- 患有并发症的老年患者经常被排除在这些试验之外.
- 需要现实世界的数据来评估多种HFrEF种群中的达帕格利弗洛辛.
研究的目的:
- 评估达帕格利弗洛辛在HFrEF患者中的实际有效性和安全性.
- 评估左心室喷射率 (LVEF),实验室参数和临床事件的变化.
- 确定患有不良事件风险较高的患者子组.
主要方法:
- 对155名HFrEF患者进行了回顾性研究,这些患者开始服用达帕格利弗洛辛.
- 患者作为自己的对照,平均随访时间为15.3个月.
- 比较LVEF,实验室值和时间依赖事件在启动前后.
主要成果:
- LVEF显著改善 (29.2%至34.3%,P<.001). 没有任何变化.
- 体重和心率下降 (P < .001).
- 功能下降 (GFR 67.6至55.2毫升/分钟/1.73米2,P <.001),特别是在老年患者中.
结论:
- 达帕格利弗洛辛在现实世界HFrEF患者中显示出有利的安全概况和血液动力学益处.
- 它改善了LVEF,并稳定了HF的进展.
- 监测功能至关重要,特别是在老年患者中.
相关概念视频
01:30Heart Failure V: Medical Management
26
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
26
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
511
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
511
01:22Heart Failure Drugs: Diuretics
495
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
495
01:22Heart Failure Drugs: β-Blockers
435
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
435
01:26Heart Failure III: Clinical Manifestations
49
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
49
01:29Heart Failure II: Pathophysiology
45
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
45